Article Type: Research Article Article Citation: Subhas Chandra Datta Ph.D.. (2020). ACACIA
AURICULIFORMIS-EXTRACT SYNTHESIS PR-PROTEINS DEVELOPED POTENTIAL BIOMEDICINES-VACCINE
AGAINST OKRA-DISEASES AND COVID-19: IMPROVED SCIENCE TECHNOLOGY COMMUNICATIONS
BIO-ECONOMY APPLICATIONS. International Journal of Research -GRANTHAALAYAH, 8(10),
249-270. https://doi.org/10.29121/granthaalayah.v8.i10.2020.1893 Received Date: 04 October 2020 Accepted Date: 31 October 2020 Keywords: Acacia
Auriculiformis-Extract Synthesis-PR-Proteins Developed-Potential-Biomedicines-Vaccine Okra-Diseases-and-COVID-19 Improved-Science-Technology-Communications Bio-Economy-Applications The
pandemic COVID19, effects on global health, educations, clinical research,
human civilization, and the economy. So, it has been an urgency to develop
proper vaccines against coronavirus. India emphasis on the most nutritious
economically-important number-one-consumption-vegetable, okra, used in many human
diseases, is naturally infected by different pathogens and significantly
reduces production. Though pesticides are the most effective means of control,
but they are expensive and toxic to the environment. So, it will require new
and more efficient solutions, technologies, products, and methods. Present pre-
and post-treatment with biomedicines; Acacia auriculiformis-extract, prepared
from the funicles of Acacia auriculiformis A. Cunn., dissolved in sterile tap
water at 1mg/10ml, were applied by foliar spray once daily for 15 days @ 10
ml/plant, against Root-Knot (RK), Yellow Vein Mosaic Virus (YVMV) and Okra
Enation Leaf Curl Virus (OELCV) diseases of okra, (Abelmoschus esculentus L.
Moench) cv.Ankur-40. The soluble root-proteins were separated by using sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and were scanned
with a recording densitometer electrophoretic scanner, measuring the molecular
weight of proteins. Pre- and post-treatment with high-diluted-biomedicines;
Acacia auriculiformis extract, were highly effective in reducing different
okra-diseases by synthesis of new pathogenesis-related-protein (PR-proteins),
inducing their natural defense-response against pathogens-infection and
enhanced their growth as well as protein content of fruits and roots. The
high-diluted-biomedicines; Acacia
auriculiformis extract, not only used as a potential-biomedical-drugs or
vaccine against various plant-diseases, by synthesis of new PR-proteins,
increasing natural-defense-response, but also, it may help for the preparation
of a vaccine against COVID-19, by increasing immunity and enriching science and
technology communications applications, cost-effectiveness and biodiversity
conservations as well as bio-economy-applications issues, reviving human
civilizations in the old form. And in near future okra may itself be a
‘Potential Biomedicine as well as Vaccine’ and world will return in normal form
by defeating COVID-19.
1. INTRODUCTIONThe COVID19, pandemic problems [1], effects on our private, professional life, social life, and the social-organization-communities [1], global health, travel, economy, and human civilization, as well as the clinical research, with scientists, has been an urgency to develop vaccines against coronavirus [2] for the unusual viral pneumonia in patients and different animals [3], forming the fifth endemic coronavirus, leaping from animals to humans, becoming a health danger [4]. It is reported that wildlife contains many coronaviruses that could potentially emerge in humans in the future due to very closely related animal-human virus [5], genetic resistance [6], divergence, structural and the future evolution, adaptation, and spread [7], prevails among humans for a long time as an asymptomatic patients [8], and recent, pandemic situation is analogous to war, the delay of every week in the deployment of a vaccine to the seven billion humans on earth will cost thousands of lives [9]. For this, WHO responses to the outbreak, the research and development blueprint has been activated to accelerate diagnostics, vaccines, and therapeutics for this novel coronavirus [10]. To meet the challenge of the pandemic problems, India emphasis on the most economically important number one consumption-vegetable crop [11], okra, used as traditional medicine, the ‘Nature's Gift to human disease-free healthy life’ [12], consumed in a variety of ways, fruits rich in vitamins, calcium, folic acid, carbohydrates, phosphorus, magnesium, and potassium [13], iodine, and other mineral matters, and a good source of superior nutritional quality -oil and –protein, unsaturated fatty acids such as linoleic acid, which is essential for human nutrition, and mature fruit and stems contain crude fiber, used in the paper industry, and the mucilage of roots- and stems- is used in the sugarcane industry of India achieved first in the world [13]. But recently, in India, the production in terms of yield as well as fruit quality of okra is hampered adversely by the naturally occurring Root-Knot (RK) diseases caused by the nematode-pathogens, Meloidogyne incognita (Kofoid and white, Chitwood, 1949), Yellow Vein Mosaic Virus (YVMV) disease- and Okra Enation Leaf Curl Virus (OELCV) disease-, caused by the virus-pathogens which spreads by an insect vector, named-whitefly (Bemisia tabaci Gen). The use of chemicals is the most effective means of control, but they are expensive and not environment-friendly creating health hazards [14], [15] and the genetics-resistance [16] to YVMV and OELCV in okra, and diversity of viruses affect the production, financial losses of okra, and climatic changes impact on the global economy [17], [18]. A number of plant –bioagents [19], [20], [21] or –bio-nematicides [15], [22], [23] and intercropping [24], [25], [26], [27], and biomedicine [28], [29], [30], [31] only stand as a suitable- and useful- against different plants-, animals- and human- diseases caused by pathogens. But it remains some problems [32], [33], [34], [35]. To meet the challenge of the problems; it is already reported that the Biomedicines; Aakashmoni or Acaciasides (A&B) or Acacia auriculiformis extract, is being used traditionally to overcome various medical complications [14], [15], [19], [20], [21], [22], [28], [29], [30], [31], [33], due to presence of several medical ailments and effective bioactive phytoconstituents, and to its low toxicity and high efficacy [34], [35]. Now, to concur the both the pandemic-situations, the main aims and objectives were: to investigate new and more efficient solutions, technologies and products for controlling disease, by using biomedicines; Acacia auriculiformis-extract, prepared from the funicles of Acacia auriculiformis A. Cunn., with pre- and post-treatments, at an extremely low dose, under naturally infected very common; Root-Knot (RK), Yellow Vein Mosaic Virus (YVMV), and Okra Enation Leaf Curl Virus (OELCV) diseases of okra, (Abelmoschus esculentus L. Moench) cv. Ankur-40, in field trials, and to see the synthesis of new pathogenesis-related-protein (PR-proteins), which are separated by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and are scanned with recording densitometer electrophoretic scanner, measuring the molecular weight of the proteins. Primarily, it has been thought, though acaciasides will be the effective vaccine, but it has some cost, and takes time for preparation as well as application as a vaccine against COVID-19 [20], [33]. And to find out the most appropriate, economic, and sustainable treatment-methods against coronavirus, which may help to the preparation of a vaccine against the COVID-19 disease [1], [2], [3], [4] outbreak [9], [10] by improving our immune system [15], [19], [20], [21], [22], [28], [29], [30], [31], [33], [34], [35], [36], [37], [38]. 2. MATERIALS AND METHODS 2.1. PREPARATION OF BIOMEDICINES- ACACIA AURICULIFORMIS EXTRACTAir-dried and powdered funicles of Acacia auriculiformis A. Cunn. (Plate 1), was extracted with 90% ethanol at room temperature (25 2°C) for 15 days, filtered and removed by evaporation at room temperature (252°C). The residue, obtained after removal of the solvent under reduced pressure, was dried in a desiccator over anhydrous calcium chloride[15], [19], [22], [23], [32], [35], [39] and the crude residues were dissolved in 90% ethanol at 1mg/ml concentration and was formed the Acacia auriculiformis-extract [31], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47]. 2.2. PREPARATION OF THE PRE- AND POST-TREATMENT PLOTSThe experiment was carried out in the garden of the Department of Zoology, Visva-Bharati, Santiniketan–731 235, West Bengal, India, at an ambient temperature 25±2oC and RH 75±5% [14], [15], [22], [23], [25], [30], [48]. Four concrete plots were a mixture of sandy soil and yard manure (2:1, v/v). One untreated plot was treated with boiling water five times for dramatization and the other three plots were naturally infected with Meloidogyne incognita (Kofoid and White, Chitwood, 1949). For uniform distribution, in these three plots, soil and root samples were taken at random to determine the extent and intensity of M. incognita -pathogen infestation by mixing @ 2,37,000±2375 J2 / plot each (M. incognita juveniles) [14], [15], [22], [23], [25], [30], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58]. 2.3. PLANTATIONSAseptically germinated seeds of okra (Abelmoschus esculentus L. cv. Ankur-40) were planted with a gap of 25cm in the four plots and allowed to grow for a period of ninety-one days. The treatments-plots were: uninoculated untreated, inoculated untreated, Acacia auriculiformis-extract -pretreated, and –post-treated [15], [19], [20], [21], [22], [25], [26], [27], [28], [39], [40], [41], [42], [43], [44]. 2.4. MORTALITY TESTTwo sets (for each test), of cavity blocks with 1 ml distilled water containing 50 larvae (J2) of M. incognita were taken; one set was treated as control and the other was treated as treatment set. To assess the direct effect of biomedicines; Acacia auriculiformis-extract, by treatment -test solution (prepared by 1mg/10ml distilled water), the water was removed by pipette from all the treatment sets, and immediately replaced by 1 ml of pretreatment -test solutions of Acacia auriculiformis-extract, were added respectively. To assess the direct effect of the control solution, the control set was received 1 ml of control solution and observed with every 30 minutes interval for a period of 12 hours exposure period at room temperature (25 ± 2°C). This mortality test was replicated five times. This mortality test was replicated five times [49], [50], [51], [52], [53], [54], [55], [56], [57], [58]. 2.5. PRE- AND POST-TREATMENT WITH ACACIA AURICULIFORMIS-EXTRACTThe biomedicines; Acacia auriculiformis-extract, test- and -control solutions (1mg/10ml concentration): After 29-days, the Root-Knot (RK) diseases (Plate 2) [14,15] caused by the nematode-pathogens, Yellow Vein Mosaic Virus (YVMV) disease (Plate-3) and Okra Enation Leaf Curl Virus (OELCV) disease (Plate 4), caused by the virus-pathogens which spreads by an insect vector, named-whitefly (Bemisia tabaci Gen), are naturally occurred and at this 6-leaf stage of okra plants, all the diseases were assessed initially (before pretreatments), and pretreatments were done by foliar spray @10 ml/plant (1mg/10ml concentration) once daily for 15 days with; biomedicines Acacia auriculiformis-extract, –test solutions and -control solution respectively [31], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48]. 2.6. ANALYSIS OF RESIDUEThe residues run in a thin layer chromatography plate (TLC) with the standard; Acacia auriculiformis extract, treatment test substances respectively [40], [41], [42], [43], [44], [45], [46], [47], [48]. 2.7. HARVESTINGNinety-one days after plantation of germinated seeds of okra, all the plants were uprooted from each plot and the parameters of growth and nematode infection such as biomass of shoot and root, root gall number, nematode population per gram of root and 200 soil, fruit and root total protein fraction in each sample was estimated [50], [51], [55], [56], [57]. At thirty days after the last pretreatment, all the parameters of diseases were assessed again (after last pretreatments) for each group and all the data were used for statistical analysis by Student t-test [31], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47] and all the data were considered and were presented in Table 1. 2.8. PREPARATION OF ROOT PROTEINSFresh roots of okra plants of 4-groups were collected at random and root pieces were homogenized with distilled water using mortar and pestle followed by glass tube homogenizer [56], [57]. The extracts were then centrifuged at 3,500 rpm for 15 minutes at 40C in Remi C-24 refrigerated centrifuge and the supernatants were collected. All the samples were transferred into lyophilizer and after lyophilization, the powdery extract was stored (-200C) for protein separation [56], [57], [58], [59], [60]. 2.9. DENSITOMETER SCANNINGAnalysis of total soluble roots proteins separation was carried out essentially by the method of Laemmli [59], [60], by using one-dimensional vertical sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), with the modification as suggested by the LKB Instructional Manual (1986). A 10% separating gel and 5% stacking gel were used. Samples for the preparation of electrophoretic run were mixed with 2x treatment buffer. A sample of 65ml of root protein extract was loaded along with dye. The bands were scanned with recording electrophoretic scanner (Biomidi, 96-300 Densitometers, Pare de La Plaine, France). The observation was recorded from the densitometers scanning curve measuring the total number of root-proteins with molecular weight. Wide range markers (k) of Pharmacia United Ltd., Sweden, were used as the standard, for the molecular weight estimation of proteins [59], [60]. 2.10. SCIENCE AND TECHNOLOGY COMMUNICATIONS APPLICATIONSThe activity and the importance of “ Pre-and Post- Treatment with Acacia auriculiformis extract, at an Extremely Low Doses, Use as Potential Cost-Effective Biomedicines Against Various Pathogens including COVID-19: Enriching Science and Technology Communication Green-economy Applications and Healthcare-, Defense response- and Immunity- as well as Biodiversity Conservation- Issues” in different audiovisual media (TV channels), social media, web pages, newspapers, and journals are recorded, which is a platform to promote and discuss different new issues and developments by publishing [14], [15], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [61], [62], [63]. 2.11. DEVELOPMENT OF IDEAS FOR PREPARATION OF A VACCINESIt will be achieved from typical analysis or justifications of literature review, reports of clinical research trials, or fields note. Then the development of new ideas or hypotheses for the preparation of vaccines against COVID-19, will arise and open the new window of future research for global-good health [14], [15], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [61], [62], [63]. 3. RESULTS3.1. TOXICITY TEST ON MORTALITYThe biomedicines; Acacia auriculiformis extract, at extremely low doses, had no direct toxic effects on nematodes mortality respectively. 3.2. ANALYSIS OF RESIDUES TOXICITYOkra leaves and fruits, collected fifteen days after the last pretreatment did not contain any toxic residue of the biomedicines; Acacia auriculiformis extract. 3.3. ROOT-KNOT AND FOLIAR DISEASESTable 1 shows the pre- and post-treatment effects of high diluted biomedicines; Acacia auriculiformis extract, at extremely low doses, on Root-Knot (RK) disease, and Yellow Vein Mosaic Virus (YVMV) and Okra Enation Leaf Curl Virus (OELCV) foliar diseases of okra plants, assessed initially (Day- 0) means before pretreatments and after a period of 30 days (Day -30) means after last posttreatment, in a field trial with the number of common-shared root-protein in comparison to uninoculated untreated one (P<0.01 by ‘t’- test). All the pretreatments with biomedicines; Acacia auriculiformis-extract, significantly reduced the root-knot and foliar diseases in comparison to the first two plots; uninoculated untreated (control) and inoculated untreated ones. Though, all the plant's groups, average; the number of leaves, number of nematodes in soil, biomass of shoots, and protein of fruits, are significantly increased than inoculated untreated plants group, but average; the biomass of roots, number of root galls and nematodes populations in roots and root protein content percent, is higher in the inoculated untreated one. The highest number of common-shared root proteins are seven in healthy uninoculated untreated control plants and the lowest number is one in the inoculated untreated one (Table 1 and Fig. 1). Table 1: Effects of the Acacia auriculiformis extract treatments groups of okra plants infected with root-knot, YVMV and OELCV diseases
‘a,b,c,d,e’- means different small letter in a column indicate significant difference (P<0.05) by ‘t’-test. ‘x,y’- means different small letter in a row indicate significant difference between day-0 and day-30 (P<0.01) by ‘t’-test. ‘Day-0’ - means before pretreatment. ‘Day-30’ - means after posttreatment. 1a: Uninoculated Untreated 1b: Inoculated Untreated 1c: Acacia auriculiformis
Pretreated 1d: Acacia auriculiformis
Post-treated Figure 1: Densitometric
tracings of root proteins of okra plants resolved on acrylamide gel (SDS-PAGE). 3.4. ROOT PROTEINS OF THE OKRATable 2: Molecular weight (k) of the root proteins of the Acacia auriculiformis extract treatments groups of okra plants
‘-‘ indicate no band Table 2 and Fig 1; shows the molecular weight (k) of the root proteins of the different groups of okra plants, pre- and post- treated with high diluted biomedicines; Acacia auriculiformis extract, at extremely low doses, on Root-Knot disease, and Yellow Vein Mosaic Virus (YVMV) and Okra Enation Leaf Curl Virus (OELCV) foliar diseases of okra plants. An analysis of root proteins of all groups by electrophoresis and densitometer scanning of all the test plants show that all the Acacia auriculiformis extract, treatments resulted in the increased number of proteins in the roots; the lowest number of protein is 11 in the uninoculated untreated roots and highest number of proteins, are 18 in the pretreated- and post-treated- Acacia auriculiformis extract, roots respectively (Table 2 and Fig. 1). The highest molecular weight of the protein is 280k (280,000kDa) and the lowest molecular weight of the protein is 12k (12,000kDa). The lowest number of the new pathogenesis-related protein (PR-proteins) is 4 in the uninoculated untreated roots and the highest number of the new pathogenesis-related proteins (PR-proteins) are 15 and 16, in the pretreated- and post-treated- Acacia auriculiformis extract, roots respectively (Table 2 and Fig. 1). Though, the PR-proteins of inoculated untreated is 14 (Table 2 and Fig. 1). 3.5. SCIENCE AND TECHNOLOGY COMMUNICATIONS APPLICATIONSAchieved by; campaign, aware, discuss, arrange workshops and seminars, make news, and publish as abstract regarding the importance of “Pretreated- and Post-treated- Acacia auriculiformis extract, with High-Diluted, at Extremely Low Doses; Indicate the Potential Cost-Effective Biomedicines Against Various Pathogens, Including COVID-19?”. 3.6. DEVELOPMENT OF IDEAS FOR PREPARATION OF A VACCINEThe results may fulfill the goal for the preparation of a vaccine for the treatment of coronavirus, with the present treatments with the high-diluted biomedicines; Acacia auriculiformis-extract, at extremely low doses, against COVID-19, need to develop future research of medicines after discussion. 3.7. FUTURE IDEAS IN RESEARCHHere, the results fulfill the goal of a research title because the present treatments with biomedicines; Acacia auriculiformis-extract, at extremely low doses, with regular consumption of nutritious okra-vegetables of need to justify future research ideas. 4. DISCUSSION4.1. PLANT PATHOGENS CAUSED DISEASESAll the high-diluted biomedicines; Acacia auriculiformis extract, at extremely low doses, ones again not only reduced Root-Knot (RK) disease, and Yellow Vein Mosaic Virus (YVMV) and Okra Enation Leaf Curl Virus (OELCV) foliar diseases of okra plants but also improved the nutritive value (especially protein) of both the treated-fruits of the naturally infected plants [15], [19], [20], [21], [22], [25], [26], [27], [28], [39], [40], [41], [42], [43], [44]. It is noted that pretreated with highly-diluted Acacia auriculiformis-extract, at extremely low doses, is less effective than post-treated with highly-diluted Acacia auriculiformis-extract. So, it can be used for controlling all naturally occuring other plant diseases also. 4.2. TOXICITYThe present study clearly showed that the high-diluted biomedicines; pretreated- and post-treated- Acacia auriculiformis-extract, were effective or potential biomedicine at extremely low doses and it had no direct toxic effect on okra plants but to the pathogens of nematodes [31], [38], [40], [41], [42], [43], [44], [45], [46], [47], [48]. So, it may be used directly against diseases of plants and animals. 4.3. SYNTHESIS AND DISEASE RESISTANCE MECHANISMSAll the biomedicines; Acacia auriculiformis-extract, could induce synthesis of some antagonistic substances in the pretreated plants [14], [15], [19], [20], [21], [22], [23], [33], [48], [53], which resist against pathogens, such as lectins accumulated in gall-regions of the root of Hibiscus esculentus infected with M. incognita [64], [65], [66], [67], [68]. Systemic acquired resistance can be induced by in different crop plants by localized virus infection, non-pathogenic and pathogenic microorganisms, or their culture filtrates or by salicylic acid [69], [70], [71] or by the polar vesicle [72] or by the defense-related triterpene glycoside avenaacin A-1 is synthesized [73]. So, it can be used against diseases of plants and animals. 4.4. DEFENSE RESPONSE ON PATHOGENESIS-RELATED (PR) PROTEINSIt is reported that a plant plasma membrane ATP binding cassette-type transporter [74] is involved in antifungal terpenoid, for this transporter in disease resistance or by the share of common antigens with its host plants [75] or by the pure compounds of acaciasides [76], [77], [78], [79], which use against pathogens. Treatments with the biomedicines; highly-diluted Acacia auriculiformis-extract, at extremely low doses, all the test plants synthesis of various proteins (antigens), and lowest number of the new pathogenesis-related protein (PR-proteins) is 4 in the uninoculated untreated roots and highest number of the new pathogenesis-related protein (PR-proteins) is 16 in the Acacia auriculiformis-extract, post-treated roots, which induce defense responses involving several pathogenesis-related proteins, specially low molecular weight proteins, in which the naturally infected plant pathogens fail to tolerate, like the NE (nematode extract) [15], [20], [21], [22], [23], [48], [80], because during natural infection with pathogen, host plant showed minimum defense responses for the antigenic (proteins) similarity [75], [81] and it is proved from the inoculated untreated pretreatment okra plants and the high-diluted drugs; Acacia auriculiformis-extract-treated roots, produce highest number of new PR-proteins, 15 and 16 respectively. So, Acacia auriculiformis-extract treatments may be used directly against diseases of plants and animals, by improving immunity or defense responses with the help of new PR-proteins [81], [82], [83], [84], [85]. 4.5. BIODIVERSITY CONSERVATIONSThose showed that nematode pathogens infestation somehow serves as a repressor for the expression of defense gene in plant [2], [3], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18][19], [20], [21], [22], [28], [29], [30], [31], [33], [34], [35], [36], [37], [38], [44], [45], [47], [48], [52], [53], [54], [81], [82] and it can be assumed that the Acacia auriculiformis-extract -treated-biomedical drugs, serve as a stimulus for the expression of many new induced defense-related PR-proteins by systemic acquired resistance [65], [68], [69], [70], [81], [82], in which plant immune systems increased pathogen resistance, as well as pathogen inhibition of such defense responses [81], which is governed by defense response genes encoding for the production of various pathogenesis-related (PR) proteins [82], serving a very cost-effective eco-friendly phytomedicine and promoted growth of test plants and this high-diluted treated-biomedical drug conserved our biodiversity conservations. Now the key question is; whether plant-derived natural products, the high-diluted Acacia auriculiformis extract-treated-biomedical drugs, at an extremely low dose, can be used as potential cost effective-biomedical by inducing defense-response against various plant-pathogens causing major (okra-) diseases in a field trial and effective against animal pathogens also? [14], [15], [19], [20], [21], [22], [23], [30], [31], [48], [80], [81], [82], [83], [84], [85]. Now the key answer; is, the high-diluted Acacia auriculiformis extract-treated-biomedical drugs, at an extremely low dose, are not only highly effective in ameliorating different plant diseases? [14], [15], [19], [20], [21], [22], [23], [30], [31], [48], [80], [81], [82], [83], [84], [85], [28], [29], [30], [31], [48], [80], [81], [82], [83], [84], [85], enriching agriculture industry as well as green biomedicine economy applications [83], [84], [85], but also may be effective against diseases of animal and human also by inducing immunity [83], [84], [85]. 4.6. DEVELOPMENT OF IDEAS FOR PREPARATION OF VACCINE· In Genome Biology: we’re not completely human, at least when it comes to the genetic material inside our cells; 145-genes from bacteria, other unicellular organisms, and viruses with 17- as possible horizontal gene transfers [85], the genomic sequencing 96.2% identical to a bat coronavirus and shares a 79.5% sequence identity to SARS-CoV [86], [87], [88], [89] deal with the structure and function of genetic material underpinning all organisms [90], [92]. Approximately, ten percent of the human genome is made of bits of virus- DNA [90]. Human endogenous retroviruses are by far the most common virus-derived sequences in the human genome [91] which don’t always require a body [92]. ·
In
Genetic Resistance: it is reported that genetic resistance to coronavirus
infection according to those three host resistance mechanisms: genetic control [16]
and SARS-CoV-2 is the etiological agent responsible for the pandemic COVID-19
outbreak and the main protease (Mpro) of SARS-CoV-2 is a key enzyme
that plays an important role in helping in viral replication and
transcription-structure-based design of antiviral drug [93]. · In Immune System Blueprint: once the virus infects the host cell, it takes over the host cell’s machinery to become a virus factory. When the human body is attacked by germs, the immune system kicks into gear to fight, by improving the immune system, creates a blueprint of the attacking agent, by which, the body effectively remembers the germ - enabling a person to fight for re-infection by the same or similar viruses [94]. · Traditional Medicine in Human History: in the evolution of human history shows the people are using traditional medicine for therapeutic purposes, and the 70%- 80% population is primarily dependent on animals and plant-based [10], [95]. · Therapeutic Value of Traditional Medicines: it is reported that the biomedicine or phytomedicine- Acacia auriculiformis extract or Acaciasides (A&B) is being used traditionally to overcome various medical complications like sore eyes, aches, rheumatism, allergy, itching, and rashes. Besides, it has also been proven for many pharmacological activities like central nervous system depressant activity, antioxidant, antimicrobial, antimalarial, antifilarial, anticestocidal, antimutagenic, chemopreventive, spermicidal, wound healing, hepatoprotective and antidiabetic activity due to its low toxicity (LD50 = 3741.7 mg/kg) and high efficacy and the various phytochemical investigations reveal the presence of chief constituents as flavonoids and triterpenoid saponin glycosides. The low toxicity and the presence of major bioactive phytoconstituents like flavonoids and triterpenoid saponin glycosides are responsible for a therapeutic remedy for various diseases and pharmacological activities respectively. It has been used to treat several medical ailments due to its low toxicity and the presence of bioactive phytoconstituents [34]. Isolated saponins (acaciasides -A&-B acylated triterpenoid bisglycoside) from fruits (funicles) of A. auriculiformis were screened for their antifilarial activity and results were found to be significant [96]. A US patent claimed the potential of acaciasides (A&B) isolated from Acacia auriculiformis for the prevention of HIV infection and as a vaginal contraceptive [97]. And it has long been not only used in traditional medicine and but also as a food source for different functions [33]. Its essential oils has hepatoprotective- and hepatic non-toxic- effects, and as a natural source of hepatoprotective agent [98]. But, 4th May 2020, WHO considered as possible treatments for COVID-19 and should be tested for efficacy and adverse side effects? [98] ·
Therapeutic
Approach: recently, the NovavaxInc, which contributed to the development of
other epidemic vaccines, has announced it is currently in pre-clinical animal
trials for several multiple nanoparticle COVID-19 vaccine candidates, by using
their recombinant protein, the adjuvant is ‘saponin-based’ and it has shown a
“potent and well-tolerated effect” [97], [99]. Scientists are trying to discover novel
inhibitor molecules against enzymes Mpro and ACE2 by the use of phytochemicals,
which be utilized for further innovation and development of antiviral compounds
against Coronavirus [100]. · Vaccination: so, for successful vaccination requires four components. Human Immunomics Initiative (HII) aims to decode the underlying mechanisms and rules of how the human immune system fights disease with advances in computing and artificial intelligence, genomics, systems biology, and bioinformatics100. And should follow the guideline of WHO entitled “Vaccine-preventable diseases and vaccines” [10], [101], [102]. It reduces wait time for emergency vaccination [103] and one or more randomized trials will be needed to answer [104]. Then, with allopath is using trial and error method in some cases to treat COVID-19 [98], [105] and according to the World Health Organization’s latest table of COVID-19 vaccines, 124-candidates with technologies or platforms. Merck’s new investments focus on two different COVID-19 vaccines that are already in early clinical trials [106]. · Development of ideas for treatment: in this situation, it will be essential to inform public health expertise for moving academic research [107] with “Return to Work” [108] and a gradual, stepwise approach to reopening. And, the present results and discussion, fulfill the goal for the effective treatments methods, because the present treatments with the Acacia auriculiformis-extract, prepared from the funicles of Acacia auriculiformis, mixed with water at an extremely low dose [15], [19], [20], [21], [22], [23], [28], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48] need to justify [98] for immunomodulatory effect [109]. 4.7. CAUSES FOR APPLICATIONS OF TREATMENT AGAINST COVID-19Recently, in lower-income countries, cause excess deaths due
to closer inter-generational-contact, largely negated, and poorer health care
benefit [110].
On the other hand, Yemen was grappling with “the largest humanitarian crisis in
the world [111].
So, we urgently need effective drugs for coronavirus disease 2019 (Covid-19),
but what is the quickest way to find them? [112]
For this, apply the plasma from COVID-19 survivors to help save others [114].
Recent trials, the Max Planck Institute test with plant extract [98], [114]
and News Drug Target Review’s therapeutics and vaccines against the novel
coronavirus disease [99]. So, I think, though it is maybe applicable as
a vaccine, but it will not be cost-effective and affects biodiversity in
conservation with green economy applications [14], [15], [19], [20], [21], [22], [23], [30], [33].
Hence, the high-diluted biomedicines; pretreated- and post-treated- Acacia auriculiformis extract, [36], [37], [38], [44], [45], [47], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47],
may be used in vaccine formulations to regulate immune function by acting as
-antioxidants and -scavenge oxidative stress [14], [15], [19], [20], [21], [22], [28], [29], [30], [34], [35], [115]
due to the presence of chief constituents of many human health care potential
biologically active chemical compounds that work through several modes of
action; flavonoids and triterpenoid saponin glycosides. The low toxicity and
the presence of major bioactive phytoconstituents like flavonoids and
triterpenoid saponin glycosides are responsible for a therapeutic remedy for
various diseases and pharmacological activities respectively. It has been used
to treat several medical ailments due to its low toxicity and the presence of
bioactive phytoconstituents [33], [34].
Isolated saponins (acaciasides -A&-B acylated triterpenoid bisglycoside)
from fruits (funicles) of A. auriculiformis were screened for their antifilarial
activity and results were found to be significant [33], [34], [35].
A US patent claimed the potential of acaciasides (A&B) isolated from A.
auriculiformis for
the prevention of HIV infection and as a vaginal contraceptive [96], [115]. 4.8. SITUATIONS FOR APPLICATIONS OF DRUGS AGAINST COVID-19Recently, novel coronavirus infection shows new symptom, COVID-Toes among the kids [116] and on the other hand current pandemic locust attack in India causes the new crises of food securities [117], and substantial excess deaths in lower-income countries due to the poorer health care available [110], humanitarian crisis [111], the world has joined hands to find a vaccine for the novel coronavirus. At present, many groups (80) are working globally for vaccines for humans which normally take years to develop. Currently, there are [112] potential vaccines for the SARS-CoV-2 which are in different stages of clinical trials [118]. In this situations, it is thought that the personalized medicines, may improve medical decision-making individualized diagnosis, prevention, and treatment of diseases [119], because an institute of public organization of developing countries, with the support of WHO, was an example for the production of vaccines, and to distribute free for all the population in Brazil, succeeding to be an important producer, became the “bad example” [120]. So, the present treatments with the high-diluted Acacia auriculiformis-extract, biomedical drugs, at an extremely low dose, should be immediately applied against pandemic COVID-19 for beneficial clinical treatments, with no side effects [121], [122], [123], [124]. 4.9. EMERGENCY EFFECTIVE APPLICATIONS OF VACCINEFirst emergency preparations of vaccine for all patients; The high-diluted biomedicines; Acacia auriculiformis extract, prepared from the funicles of Acacia auriculiformis, @ 5-10 drops mixed with 10-20 ml of sterile distilled- or pure drinking -water, maybe orally administered twice daily in the early morning and evening respectively (before taking any food) for 10-15 days, depending on age and body weight, against naturally occurring novel coronavirus infections,15-days before symptom onset OR illness onset (as a vaccine) OR onset of symptoms where patients in hospital-associated COVID-19 infections have been reported (treatments) [31], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [115], [119], [122], [124]. In the case of the application of drugs for treatment, depending on the disease intensity, the dose may be increased 3-5 times a day. It is cost-effective, eco-friendly, and easy -prepare able and –available and emergency applicable drug [33], [122], [123], [125]. It is obligatory that information on ClinicalTrials.gov, a resource provided by the U.S. National Library of Medicine (NLM), to the National Institutes of Health (NIH) or World Health Organization or other agencies of the U.S. Federal Government, is provided by study sponsors and investigators, and they are responsible for ensuring that the studies follow all applicable laws and regulations [95], [101], [102], [116], [122], [123], [125], [126], [127], and these concerned authorities should give permission for direct-emergency [119], [120], [121], used of biomedicines; Acacia auriculiformis extract, -liquid against COVID-19 [33], [39], [44], [98], [99], [102], [103],[105], [115], [122], [123], [124], [125], which is well known with the generalized concept of medicines for emergency apply [119], [120], [121], [122], [123], and this drug serve as emergency-medicines, like antibiotics, leading to a generalized concept of medicine for emergency-applications [123], [126]. It is the most cost-effective [122], [123], easily prepare able [114], [115] easily available [20], easily applicable [119], [120], [121], [127] and help in biodiversity conservations and green economy applications against COVID-19 also [31], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [98], [105], [115], [116], [125], for the nonspecific benefits as well as immunity to the target pathogen? [128]. It is known that our body as a complex system, has the capacity for self-organization, emergence and self-similarity over global (overall health, education, social and economic structure, and wellbeing) and local (organ) levels of organization and these features are key for future research on the systemic healing that evolves over time during individualized emergency treatment with biomedicines Acacia auriculiformis extract [129], [130], [131], [132], which is a complex nano-scale system involving multiple inter-connected, interacting components, and emergent properties [132]. So, it is the most; cost-effective, easily prepare able, easily available, and helps in biodiversity conservations and green economy applications issues and easily applicable also with increasing immunity [128] and the high-diluted biomedicines; Acacia auriculiformis extract, is the best emergency effective applicable treatment potential biomedicine [33], [39], [44], [98], [99], [102], [103],[105], [115], [122], [123], [124], [125], against COVID-19. It is also studied the cost-effectiveness of emergency care interventions in low and middle-income countries like India [120], [121], [122], [123], [124]. Second emergency preparations of vaccine for general and nondiabetic patients; The high-diluted Acacia auriculiformis extract, -globules, prepared from the few drops of a liquid Acacia auriculiformis extract, by pouring and to just moistening all the sucrose-globules in the vial forming Acacia auriculiformis extract, -biomedicines-globules [31], [36], [37], [38], [39], [40], [42], [43], [44], [45], [46], [47], [115], [119], [122], [123], [124], @ 10-20 medicated-globules (7.2-14.4mg), maybe orally administered thrice daily in the early morning, afternoon and evening (before taking any kinds of food) for 10-15 days, depending on age and body weight, against naturally occurring virus infections 15-days before symptom onset OR illness onset (as a vaccine) OR onset of symptoms where patients admitted in hospital with COVID-19 infections have been reported (treatments) [123]. In the case of treatment, depending on the disease intensity, the dose may also be increased 3-4 times a day. It is also the most cost-effective and easy -prepare able, –available, and easy-applicable drug [122], [123], [124], [125]. The biomedicine Acacia auriculiformis-extract, -globules can also be directly used for emergency effective treatment of COVID-19 after getting permission from the; -WHO, -ClinicalTrials.gov., -U.S. NLM and –NIH [95], [101], [102], [116], [122], [123], [125], [126], and the concerned authorities, should give permission for direct-emergency used of biomedicines Acacia auriculiformis-extract,-globules against COVID-19, because for no side effects [33], [115], [119], [122], [124], [125], and serve also as antibiotics, leading to a generalized concept of medicine [123], [126], [127], [128], [129], [130], [131], future research on the systemic healing that evolves over time during individualized emergency applications [131], with multiple interconnected, interacting components, and emergent properties [132]. It is the most; cost-effective, easily prepare able, easily available, and helps in biodiversity conservations and green economy applications issues and easily emergency-applicable also with increasing immunity [128] and it is the best emergency effective applicable treatment methods [33], [39], [44], [98], [99], [102], [103],[105], [115], [122], [123], [124], [125], against COVID-19, without spending time and it also becomes the most cost-effectiveness of emergency applicable-care interventions in low and middle-income countries like India [120], [121], [122], [123], [124], [125]. Third emergency preparations of vaccine for all patients; The adjuvant Acacia auriculiformis extract, [33], [98], [114], [115], may be used with recombinant protein nanoparticle antigens derived from the coronavirus spike protein and combine these antigens with its adjuvant Acacia auriculiformis-extract for the final formulation of the vaccine and it may be shown a “potent and well-tolerated effect” through stimulating the entry of antigen-presenting cells into the injection site and enhancing antigen presentation in local lymph nodes, boosting immune responses [31], [36], [37], [38], [39], [40], [42], [43], [44], [45], [46], [47], [97], [98], [99], [113], [114], [115], [133]. In a letter as an e-mail, the Science Advisory Board Net, at Express Cells, for their business of creating better knock-in cell lines for drug discovery, toxicology, and other biologic research and add for purchase SARS-CoV-2 Spike Protein (NC_045512.2), SARS-CoV-2 Nucleocapsid Protein (NC_045512.2), TMPRSS2 (NM_001135099.1), ACE2 (NM_021804.3), BSG (CD147) (NM_001728.3), SARS-CoV Nucleocapsid Protein (MK062179.1), SARS-CoV Spike Protein (MK062179.1), MERS-CoV Nucleocapsid Protein (NC_019843.3), MERS-CoV Spike Protein (NC_019843.3) [133] and the readily available coronavirus spike proteins may be helped to use for vaccine preparation which may fight against “COVID Toes among kids: New symptom of novel coronavirus infection” [116]. Here, vaccination or treatments, is the use of remedies against diseases either earlier in an epidemic or given routinely to prevent diseases. When the latter is used it involves mostly the users just like any conventional vaccination which administers the antigen in an inactive state to gain immunity towards the disease and is given before the onset of disease or disease symptoms in an individual as a prevention rather than cure [122] and in a clinical study shows the efficiency of triple antibiotic mixture and propolis as intracanal medication in revascularization process in immature apex [122], [134]. It is obligatory that information to the ClinicalTrials.gov, the U.S. National Library of Medicine, to the National Institutes of Health or other agencies of the U.S. Federal Government [95], [101], [102], [116], [122], [123], [125], [126], [127], and maybe easily emergency-applicable drugs with increasing immunity [128]. Fourth emergency
preparations of vaccine for all patients; The adjuvant Acacia auriculiformis extract, [33],
[39], [98], [114], [115] maybe used with
anti-Human antibodies like IgG (A80-104A, A80-105A), IgM (A80-100A, A80-101A),
& IgA (A80-102A, A80-103A) and offer treatments or vaccine preparation of
COVID-19 (SARS-CoV-2) and it may also be accelerated the discovery to improve
lives [33], [101], [115], [116], [122],
[126], [127], [133], [134], [135], [136].
After getting successful clinical trials, the concerned authorities may be
permitted for the use as a vaccine for emergency preparation for treatments
against novel coronavirus [95], [101], [102],
[116], [122], [123], [125], [126], [127]. Note for emergency
applications; Recently, the NovavaxInc, has announced it is currently in
pre-clinical animal trials for several multiple nanoparticle COVID-19 vaccine
candidates, the adjuvant is ‘saponin-based’ [33],
[97], [98], [99], [115].
Merck’s new investments focus on two different COVID-19 vaccines that are
already in early clinical trials [33], [106], [115]
and the Max Planck Institute test plant extract [98], [114]
against the novel coronavirus disease with little toxicity and
artemisinin-based saponin-content drugs are widely used to treat malaria even
in newborns [102], [106], [114].
In this pandemic situations, it is thought that the high-diluted biomedicines (liquid
and globules); Acacia auriculiformis-extract,
at the above-mentioned doses, the personalized medicines, may improve medical
decision-making individualized diagnosis, prevention, and emergency applicable
cost-effective treatments against COVID-19 diseases [119], with the support of WHO,
NIH, ClinicalTrials.gov. and U.S. NLM, showing an example for the ‘Use,
Production and Emergency Application of Vaccines’, and to distribute free for
all the population [95], [101], [102],
[116], [122], [123], [125], [126], [127]. Because, all the high-diluted Acacia auriculiformis-extract, -liquid
and –globules biomedicines, are making them capable for different biological
activities and expected to be effective against Covid-19, and the U.S. Centers
for Disease Control and Prevention (CDC) and the World Health Organization
(WHO), want to apply safe vaccine against SARS-CoV-2, for the newly developed-late
hyperinflammatory multisystem inflammatory syndrome in children (MIS-C) and
adults with Covid-19 [33], [115], [136], [137]? Science and Technology Communications Biomedicines Applications; Recently, the Coronavirus pandemic has adverse effects on education, especially on school education and characteristics, including research, academic programs, staff professional development, and jobs also [129]. At present, many groups (80) are working globally for vaccines for a human which normally takes years to develop. Currently, there are [112] potential vaccines for the SARS-CoV-2 which are in different stages of clinical trials [118] and a committee that makes vaccine use recommendations to the U.S. Centers for Disease Control and Prevention (CDC), suggesting they should be high on the list [138]. Because, the behavioral scientists provide a road-map for the public to manage the trauma of COVID-19 and its aftermath successfully, learned from biomedical science [139], and gird for a war on vaccine misinformation [140]. While a cure or vaccine for COVID-19 is not available, in the absence of any side-effects and adverse interactions with any conventional medicines along with a robust safety profile and repeated evidence-based successes against viral infections, the high-diluted biomedicine (liquid and globules); Acacia auriculiformis extract, at an extremely low dose, may play an important role in the fight against COVID-19 [122], [123], [124]. It is the most; cost-effective-methods, easily prepare able, easily available, and help in biodiversity conservations and green economy applications issues also [31], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [98], [105], [115], [116], [125] and should be use as emergency applicable methods against COVID-19 as early as possible [105], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129] for taking measures or treatment opportunities or avoid new coronavirus infections. And immediate apply by; campaign, aware, discuss, arrange workshops and seminars, make news, and publish as abstract regarding the importance of “The Biomedicines (liquid and globules) Acacia auriculiformis extract, at extremely low doses; Indicate the Potential Cost-Effective Biomedicines Against Various Pathogens including COVID-19 by Improving Immunity”. Future Ideas in
Research Vaccine; Here, the results fulfill the goal of a research title
because the present treatments with biomedicines; Acacia auriculiformis-extract, at extremely low doses, with regular
consumption of okra vegetables of need to justify future research ideas. It is
known that social vaccines resist and change unhealthy social and economic
structures and useful metaphor for health promotion [130].
Okra plants itself may serve as a good “Eco-Friendly Highly Economical Plants
as well as Biomedicines” thereby reducing diseases conserving our biodiversity
contributing towards “Sustainable Climate Health and Development” and it may
have important economic implications in agriculture to fulfill its food and
nutrition requirement and improved midday meals by preventing malnutrition. And highly-trace-tolerance-okra may be used,
in vaccine formulations or treatments or social vaccine, as one of the most
powerful potential-biomedicine, improving natural immunity against COVID-19,
enriching science and technology communication applications food security
economy. It may be the most; cost-effective, easily-available, safe-edible and
prepare able as well as and safe alternative to live replicating COVID-19
social vaccines which restarts, a window of hope and opportunity open for
nations to green their recovery the 21st-century economy in ways that are
clean, green, healthy, safe and more resilient, and a large number of people
may be immune or resistant to SARS-COV-2
due to they have already been infected by other coronaviruses [141], [142], [143], [144], [145], [146] and Emergency Use Authorization of Covid Vaccines
— Safety and Efficacy Follow-up Considerations [146]. And Okra maybe use as future biomedicine improved immunity against COVID-19 enriching science and technology communication applications food security economy [142], [146].
Plate 1: Funicles of Acacia auriculiformis A. Cunn.
Plate 2: Root-Knot (RE) disease caused by Meloidogyne incognita of okra
Plate 3: Yellow Vein Mosaic Virus (YVMV) disease of okra
Plate 4: Okra Enation Leaf Curl Virus (OELCV) disease of okra 5. CONCLUSIONSThe biomedicines- Acacia auriculiformis-extract, at extremely low doses, not only used as a potential-biomedical-drugs or vaccine against various plant-diseases, by synthesis of new PR-proteins, increasing natural-defense-response, but also, it may be increased urgency to prepare safe and an effective emergency use for treatment for prevention coronavirus, the COVID-19, by increasing the immune system for the improvement of biomedicines economy applications science and technology communication cost-effectiveness and biodiversity conservations as well as bio-applications issues, reviving human civilizations in the old form. And in near future okra may itself be a ‘Vaccine as well as Biomedicine’, and safe alternative to live replicating COVID-19 vaccines which restarts, a window of hope and opportunity open for nations to green their recovery the 21st-century economy in ways that are clean, green, healthy, safe and more resilient. SOURCES OF FUNDINGThis research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. CONFLICT OF INTERESTThe author have declared that no competing interests exist. ACKNOWLEDGMENTThe work has been supported
by Prof. N.C. Sukul, Prof. S.P. Sinha Babu, and all the researchers of
Biochemistry Laboratory, Department of Zoology, Visva-Bharati. I am thankful to
the eminent Senior Consultant Physician & Cardiologist Dr. Tushar Kanti
Batabyal, M.B.B.S., M.D., Ex-Clinical Tutor of the Burdwan Medical College
& Hospital, for inspiration and guidance. I express my deep gratitude to
Mr. Rakesh Khan, Secretary and Mr. Subhendu Bose, President with all Young
Green-Members of the “International NGO named Burdwan Green Haunter and
Students’ Goal” for arranging to many awareness programmed on a social vaccine
against COVID-19. Last but not the least; I am thankful to the eminent
educationist Sri Tapaprakash Bhattacharya for inspiration and guidance. REFERENCES
[40] Datta SC (2006a) Effects of Cina on root-knot
disease of mulberry. Homeopathy 95:98-102.
[43] Datta SC (2010) The Role of Cina in the Field
of Enriched Sericulture. Hpathy Ezine.
[49] Fenner LM (1962) Determination of nematode
mortality. Plant Disease Reporter 46:383.
[52] Sukul NC (1987) Soil and plant nematodes.
West Bengal State Book Board Publisher pp. 1-271.
[60] Mouemar AAL, Gasquez J (1983) Environmental
conditions and isozyme polymorphism in Chenopodium albumL. Weed Research
23:241-249.
[75] Osbourn AE (1996) Saponins and plant defence–
a soap story. Trends in Plant Science 1:4-9.
[91] Callif BL (2020) The Human Genome Is Full of
Viruses. Medium, Medical Myths and Models. [107]
Barnes
M, Sax PE (2020) Challenges of “Return to Work” in an Ongoing Pandemic. Special
Reports, NEJM.org.The New England Journal of Medicine 2020.
doi:10.1056/NEJMsr2019953. [118]
Blum HE
(2020) Personalized Medicine in the Genomics Era. Internal Medicine Review
6(2):1-14. [123]
News. (2020)
Homeopathy in managing viral infections like COVID-19. BioSpectrum 10 April
2020. https://www.nih.gov/coronavirus
and https://www.coronavirus.gov.
This work is licensed under a: Creative Commons Attribution 4.0 International License © Granthaalayah 2014-2020. All Rights Reserved. |